Li Zhao

Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Single-cell transcriptomics reveals the ameliorative effect of gastrodin on cholestatic liver fibrosis.

Single-cell transcriptomics reveals the ameliorative effect of gastrodin on cholestatic liver fibrosis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 21, 2025

The gut microbe Bacteroides acidifaciens ameliorates CCl4-induced liver fibrosis.

The gut microbe Bacteroides acidifaciens ameliorates CCl4-induced liver fibrosis.

Journal: European journal of pharmacology

Published: June 29, 2025

Single-cell and bulk transcriptome analysis identifies B-cell subpopulations and associated cancer subtypes with distinct clinical and molecular characteristics.

Single-cell and bulk transcriptome analysis identifies B-cell subpopulations and associated cancer subtypes with distinct clinical and molecular characteristics.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: April 08, 2025

PET/NIR Fluorescence Bimodal Imaging for Targeted Tumor Detection.

PET/NIR Fluorescence Bimodal Imaging for Targeted Tumor Detection.

Journal: Molecular pharmaceutics

Published: November 10, 2023

Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment.

Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment.

Journal: Journal of medicinal chemistry

Published: July 06, 2023

c-Fos regulated by TMPO/ERK axis promotes 5-FU resistance via inducing NANOG transcription in colon cancer.

c-Fos regulated by TMPO/ERK axis promotes 5-FU resistance via inducing NANOG transcription in colon cancer.

Journal: Cell death & disease

Published: May 22, 2023

GL-V9 ameliorates liver fibrosis by inhibiting TGF-β/smad pathway.

GL-V9 ameliorates liver fibrosis by inhibiting TGF-β/smad pathway.

Journal: Experimental cell research

Published: November 26, 2022

Retraction Note: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation.

Retraction Note: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation.

Journal: Scientific reports

Published: May 31, 2022

AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma.

AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma.

Journal: Oncogene

Published: August 20, 2021

Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation.

Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation.

Journal: Scientific reports

Published: June 12, 2021

Vimentin loss promotes cancer proliferation through up-regulating Rictor/AKT/β-catenin signaling pathway.

Vimentin loss promotes cancer proliferation through up-regulating Rictor/AKT/β-catenin signaling pathway.

Journal: Experimental cell research

Published: January 16, 2021

Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP3R1/AKT/β-catenin pathway.

Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP3R1/AKT/β-catenin pathway.

Journal: Life sciences

Published: June 20, 2020

Showing 1-12 of 34

Last Updated: 09/26/2026